Suppr超能文献

新型冠状病毒(SARS-CoV-2)木瓜样蛋白酶(PLpro)突变与新冠肺炎临床结局的关联

Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes.

作者信息

Tan Jinlin, Wu Zhilong, Hu Peipei, Gan Lin, Wang Ying, Zhang Dingmei

机构信息

School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.

The Fourth People's Hospital of Foshan City, Foshan 528000, China.

出版信息

Pathogens. 2022 Sep 3;11(9):1008. doi: 10.3390/pathogens11091008.

Abstract

Papain-like protease (PLpro) is important for the replication and transcription of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to reveal the PLpro mutations associated with the clinical outcomes of patients. Due to the importance of the S protein in the pathogenicity of SARS-CoV-2, the mutation of the S protein was also analyzed in this study. After downloading the data from the Global Initiative on Sharing Avian Influenza Data (GISAID) database, samples were divided into two groups on the basis of patient status, namely, recovered and dead groups. This study performed a univariate analysis and further explored the association of mutations with patient outcomes through multivariate logistic regression analysis. A total of 138,492 samples were used for analysis. The patients had a mean age of 43.66 ± 21.56 years, and 51.3% of them were female. Multivariate logistic regression results showed that, compared with men, women had a lower risk of dying from coronavirus disease 2019 (COVID-19) (OR = 0.687, 95%CI: 0.638-0.740). Compared with patients aged 17 years and younger, patients aged 18-64 years (OR = 2.864, 95%CI: 1.982-4.139) and patients over 65 years old (OR = 19.135, 95%CI: 13.280-27.572) had a higher risk of death after infection. Compared with the wild type, P78L (OR = 5.185, 95%CI: 2.763-9.730) and K233Q (OR = 5.154, 95%CI: 1.442-18.416) in PLpro were associated with an increased risk of death. A synergistic interaction existed between age and mutations A146D and P78L. The results of the multivariate logistic regression analysis of the data on vaccinated patients demonstrated that, compared with the wild type, the P78L (OR = 3.376, 95%CI: 2.040-5.585) mutation was associated with an increased risk of death. In conclusion, compared with the wild-type PLpro protein, the P78L and K233Q mutations may increase the risk of death in infected individuals. In addition, a synergistic effect existed between age and P78L and K233Q that increased the risk of death in older patients.

摘要

木瓜蛋白酶样蛋白酶(PLpro)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的复制和转录至关重要。本研究旨在揭示与患者临床结局相关的PLpro突变。由于S蛋白在SARS-CoV-2致病性中的重要性,本研究还分析了S蛋白的突变情况。从全球共享禽流感数据倡议组织(GISAID)数据库下载数据后,根据患者状态将样本分为两组,即康复组和死亡组。本研究进行了单因素分析,并通过多因素逻辑回归分析进一步探讨突变与患者结局的关联。共138492个样本用于分析。患者的平均年龄为43.66±21.56岁,其中51.3%为女性。多因素逻辑回归结果显示,与男性相比,女性死于2019冠状病毒病(COVID-19)的风险较低(OR=0.687,95%CI:0.638-0.740)。与17岁及以下患者相比,18-64岁患者(OR=2.864,95%CI:1.982-4.139)和65岁以上患者(OR=19.135,95%CI:13.280-27.572)感染后死亡风险较高。与野生型相比,PLpro中的P78L(OR=5.185,95%CI:2.763-9.730)和K233Q(OR=5.154,95%CI:1.442-18.416)与死亡风险增加相关。年龄与A146D和P78L突变之间存在协同相互作用。对接种疫苗患者的数据进行多因素逻辑回归分析的结果表明,与野生型相比,P78L突变(OR=3.376,95%CI:2.040-5.585)与死亡风险增加相关。总之,与野生型PLpro蛋白相比,P78L和K233Q突变可能增加感染个体的死亡风险。此外,年龄与P78L和K233Q之间存在协同效应,增加了老年患者的死亡风险。

相似文献

3
Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics.
J Genet Eng Biotechnol. 2021 Apr 2;19(1):52. doi: 10.1186/s43141-021-00152-z.
6
Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease.
Front Chem. 2021 Feb 4;8:624163. doi: 10.3389/fchem.2020.624163. eCollection 2020.
7
Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone.
Front Chem. 2022 Feb 23;10:822785. doi: 10.3389/fchem.2022.822785. eCollection 2022.
9
Effective inhibition of coronavirus replication by .
Front Biosci (Landmark Ed). 2021 Oct 30;26(10):789-798. doi: 10.52586/4988.
10
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors.
Nat Commun. 2021 Feb 2;12(1):743. doi: 10.1038/s41467-021-21060-3.

引用本文的文献

1
A comprehensive review of current insights into the virulence factors of SARS-CoV-2.
J Virol. 2025 Feb 25;99(2):e0204924. doi: 10.1128/jvi.02049-24. Epub 2025 Jan 29.
3
The Key Site Variation and Immune Challenges in SARS-CoV-2 Evolution.
Vaccines (Basel). 2023 Sep 10;11(9):1472. doi: 10.3390/vaccines11091472.

本文引用的文献

1
GISAID's Role in Pandemic Response.
China CDC Wkly. 2021 Dec 3;3(49):1049-1051. doi: 10.46234/ccdcw2021.255.
2
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.
Nature. 2022 Feb;602(7896):294-299. doi: 10.1038/s41586-021-04245-0. Epub 2021 Nov 24.
3
5
Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada.
CMAJ. 2021 Oct 25;193(42):E1619-E1625. doi: 10.1503/cmaj.211248. Epub 2021 Oct 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验